Author Q&A: Intravenous Immunoglobulin for Treatment of COVID-19 in Select Patients

Abstract

He was the lead investigator in a study published in the May/June 2022 issue of JCOM that found that, when allocated to the appropriate patient type, intravenous immunoglobulin can reduce hospital costs for COVID-19 care.